Ads
related to: what is fda- Verify: FDA Registration
Free Tool To Verify That Your US
FDA Registration Is Currently Valid
- Contact Us
Call + Email
24/7 Live Chat
- Food & Beverage
Full Service
Everything You Need
- FDA Registration
Quick & Easy
Register Your Business
- Verify: FDA Registration
Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 2 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 2 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
WSB Radio· 8 minutes agoThe experts will discuss the quality of the evidence and safety concerns Tuesday, including MDMA's...
Recall alert: FDA announces recall of 1.9M bottles of Fiji water
WPXI· 2 hours agoThe Food and Drug Administration has announced the recall of more than 78,500 cases of Fiji Natural...
Cheese recall update as FDA issues highest level of concern
Newsweek· 2 days agoThe U.S. Food and Drug Administration (FDA) recently warned consumers that a brand of cheese...
US FDA staff raises concerns over data from MDMA-based PTSD therapy
Reuters via Yahoo News· 2 hours agoFood and Drug Administration's advisory panel on Tuesday, as the agency reviews the therapeutic use...
FDA secures approval for Human Foods Program, unifies food safety & policy oversight
Food Navigator USA· 1 hour agoThe Human Foods Program (HFP) is targeted for launch Oct. 1 after a year and a half of deliberation....
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease - Regeneron...
Benzinga· 2 hours agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
FDA Updates Fiji Recall, Downgraded To Class 3
Black Enterprise· 2 hours agoDuring the week of May 20, the FDA adjusted its concern to a Class III, which dictated that there is no relative risk of adverse health consequences. As...
FDA Staff Raises Concerns About Ecstasy Drug’s Safety in Report
Bloomberg· 2 hours agoThe US Food and Drug Administration’s staff posted briefing documents that raised concerns about the...